Range
8.03 - 8.08
Vol / Avg.
985.5K/1M
Div / Yield
-
52 Wk
2.96 - 9.15
Mkt Cap
368M
Payout Ratio
-
Open
8.05
P/E
-
EPS
-0.27
Shares
45.6M
Outstanding
45.6M
Total Float
40.7M
load more
Sector: Health Care.Industry: Biotechnology
Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.290-0.270 0.0200
REV21.950M21.972M22.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Adamas Pharmaceuticals Questions & Anwsers

Q

How do I buy Adamas Pharmaceuticals (ADMS) stock?

A

You can purchase shares of Adamas Pharmaceuticals (NASDAQ: ADMS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adamas Pharmaceuticals's (ADMS) competitors?

Q

What is the target price for Adamas Pharmaceuticals (ADMS) stock?

A

The latest price target for Adamas Pharmaceuticals (NASDAQ: ADMS) was reported by JMP Securities on October 12, 2021. The analyst firm set a price target for 0.00 expecting ADMS to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Adamas Pharmaceuticals (ADMS)?

A

The stock price for Adamas Pharmaceuticals (NASDAQ: ADMS) is $8.07 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Adamas Pharmaceuticals (ADMS) pay a dividend?

A

There are no upcoming dividends for Adamas Pharmaceuticals.

Q

When is Adamas Pharmaceuticals (NASDAQ:ADMS) reporting earnings?

A

Adamas Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 8, 2021.

Q

Is Adamas Pharmaceuticals (ADMS) going to split?

A

There is no upcoming split for Adamas Pharmaceuticals.

Q

What sector and industry does Adamas Pharmaceuticals (ADMS) operate in?

A

Adamas Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.